Pearl Huang to lead Novartis-partnered startup


Former Roche and Cygnal Therapeutics executive Pearl Huang is now the CEO and 12th employee of a tiny startup called Dunad Therapeutics.

Previous Exclusive: Enlightenment Capital raises whopping $540 million fund
Next Willow Ridge makes $10.6 million deal for two WNY nursing homes